Remote physiological monitoring (RPM), especially for patients with cardiometabolic conditions, may improve patient care and increase revenue, but not without initial investments, a new study reported ...

People with type 1 diabetes achieved significantly better long-term blood glucose when their levels were monitored by health ...

Using different oximeter devices for monitoring stable patients under NIV or CPAP may have an unpredictable effect on results and clinical decisions.

IRadimed Corporation (NASDAQ: IRMD) Q3 2025 Earnings Call Transcript November 3, 2025 IRadimed Corporation beats earnings ...

“We know from data that primary care, which sees over 90% of patients with type 2 diabetes, that there’s not much uptake or ...

This conference call contains time-sensitive information and is accurate only as of the live broadcast today, October 30, 2025. iRhythm disclaims any intention or obligation, except as required by law ...

There are forearm-based heart rate monitors, wrist-based heart rate monitors, smartwatches, fitness trackers and even ...

Adopting the proper countermeasures to protect and maintain trust in health care data will require additional collaboration ...

Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® ...

Artificial intelligence is showing up in Louisiana hospitals, from tools that help doctors read scans faster to software that ...

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 third quarter financial results before the market opens on Monday, November 3, 2025. Iradimed management will ...

Takeda (TSE:4502/NYSE:TAK) today announced that the recently FDA-approved HyHub and HyHub Duo devices are now available in the U.S. for patients 17 years of age and older, as prescribed, who are ...